The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.

Ali Riza DemirÖmer CelikSamet SevinçBegüm UygurSerkan KahramanEmre YilmazMete CemekYilmaz OnalMehmet Erturk

Published in: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc (2019)

The Tp-e interval can be used to optimize SCD risk stratification in HCM patients and determine which patients will benefit from implantable cardioverter-defibrillator (ICD) treatment.

Keyphrases

end stage renal disease
magnetic resonance
hypertrophic cardiomyopathy
ejection fraction
newly diagnosed
left ventricular
prognostic factors
heart failure
magnetic resonance imaging
atrial fibrillation
patient reported outcomes